BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7851159)

  • 1. Flow cytometric quantitation of C-myc and P53 proteins in bovine papillomavirus type 1-transformed primary mouse fibroblasts.
    Agrawal RS; Agrawal YP; Mäntyjärvi RA
    Cytometry; 1994 Nov; 17(3):237-45. PubMed ID: 7851159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of wild-type p53 and c-Myc in human fetal cells transformed with adenovirus early region 1.
    Grand RJ; Lecane PS; Roberts S; Grant ML; Lane DP; Young LS; Dawson CW; Gallimore PH
    Virology; 1993 Apr; 193(2):579-91. PubMed ID: 8460477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
    Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells.
    Gazitt Y; Erdos GW
    Cancer Res; 1994 Feb; 54(4):950-6. PubMed ID: 7906198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis.
    Janson W; Brandner G; Siegel J
    Oncogene; 1997 Sep; 15(12):1395-406. PubMed ID: 9333015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine papillomavirus type 1-transformed primary mouse fibroblasts show no correlation between tumorigenicity and viral gene expression, but c-myc gene expression is elevated in tumorigenic cell lines.
    Agrawal R; Pelkonen J; Mäntyjärvi RA
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1527-32. PubMed ID: 1318945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome.
    Scobie L; Jackson ME; Campo MS
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():3001-8. PubMed ID: 9367387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-damage-inducible p53 activity in SV40-transformed cells.
    Hess RD; Brandner G
    Oncogene; 1997 Nov; 15(20):2501-4. PubMed ID: 9395246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
    Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
    Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine.
    Havre PA; O'Reilly S; McCormick JJ; Brash DE
    Cancer Res; 2002 Mar; 62(5):1443-9. PubMed ID: 11888918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
    Xie XK; Yang DS; Ye ZM; Tao HM
    Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids.
    Yuan ZQ; Gault EA; Gobeil P; Nixon C; Campo MS; Nasir L
    Virology; 2008 Apr; 373(2):352-61. PubMed ID: 18191170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis.
    Rapp L; Liu Y; Hong Y; Androphy EJ; Chen JJ
    Oncogene; 1999 Jan; 18(3):607-15. PubMed ID: 9989810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Positive expression of c-myc and p53 products in two cases of pulmonary sclerosing hemangioma].
    Chiba W; Sawai S; Yasuda Y; Wazawa H; Matsubara Y; Ikeda S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33(12):1348-54. PubMed ID: 8821986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc.
    Han JW; Dionne CA; Kedersha NL; Goldmacher VS
    Cancer Res; 1997 Jan; 57(1):176-82. PubMed ID: 8988061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.